In this interview, Rami Mehio, head of software and informatics at Illumina, shares his experiences and contributions to major genomic projects like the UK Biobank’s whole genome sequencing. He discusses the challenges and innovations in genomic data analysis, highlighting Illumina’s role in advancing genetic research and precision medicine.
Safe Supply and Origin Therapeutics Receive Conditional Approval for Listing On the CSE | Psychedelic Invest
Safe Supply Streaming Co. Ltd. (“Safe Supply” or the “Company”) and Origin Therapeutics Holdings Inc. (“Origin”) (CSE: ORIG) are pleased to announce that they have received
October 10, 2023